Skip to main content

pMIHP-16188 AU1.OLLAS.V5
(Plasmid #241485)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 241485 Standard format: Plasmid sent in bacteria as agar stab 1 $89

Backbone

  • Vector backbone
    Retroviral plasmid
  • Vector type
    Retroviral
  • Tags / Fusion Proteins
    • AU1
    • OLLAS
    • V5

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    30°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    None

Resource Information

  • Supplemental Documents
  • A portion of this plasmid was derived from a plasmid made by
    The plasmids were generated using pro-code vectors received from Dr Brian Brown at Mount Sinai and we have their permission via email for these to be deposited.

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Any stbl competent cell strain can be used for growing this plasmid.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pMIHP-16188 AU1.OLLAS.V5 was a gift from Adrian Liston (Addgene plasmid # 241485 ; http://n2t.net/addgene:241485 ; RRID:Addgene_241485)
  • For your References section:

    The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program. Burton OT, Bricard O, Tareen S, Gergelits V, Andrews S, Biggins L, Roca CP, Whyte C, Junius S, Brajic A, Pasciuto E, Ali M, Lemaitre P, Schlenner SM, Ishigame H, Brown BD, Dooley J, Liston A. Immunity. 2024 Jul 9;57(7):1586-1602.e10. doi: 10.1016/j.immuni.2024.05.023. Epub 2024 Jun 18. 10.1016/j.immuni.2024.05.023 PubMed 38897202